English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Malignant tumors have become a common disease endangering the health of human being. According to GLOBOCAN2018, there are approximately 18.08 million new cases of malignant tumors and 9.56 million deaths worldwide. China accounts for approximately 23.7% and 30%, respectively (1,2). A majority of cancer treatment strategies are based on the removal of tumor mass mainly by surgery. chemotherapy and radiotherapy have also made a major contribution in inhibiting rapid growth of malignant cells. Furthermore, these approaches are often combined to enhance therapeutic indices (3). Currently, cancer treatment is a highly dynamic field and significant advances are being made in the development of novel cancer treatment Original Article

The knowledge, attitude and practice of hospital pharmacists on the safety issues of antitumor agents for the patients discharged in China